NCT02561039 2016-11-02
A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease
Hoffmann-La Roche
Phase 3 Completed
Clinical Trials
5 trialsNCT02564107 2016-11-02
A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease
Hoffmann-La Roche
Phase 4 Completed
NCT02716792 2016-03-23
A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer
Hoffmann-La Roche
Phase 3 Completed
NCT02553707 2015-09-17
A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00502736 2014-01-22
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
Hoffmann-La Roche
Phase 2 Completed